A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/1994
12/06/1994	US5370864 With core containing cetylphridinium chloride, acesulfame, additional artificial sweetener
12/06/1994	US5370862 Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina
12/06/1994	US5370815 Peroxidase, peroxide, iodide compound, and surfactants and buffers; enzyme generated free iodide radical
12/06/1994	US5370635 Device for delivering a medicament
12/06/1994	CA1333390C Fluorinated nucleosides and process for treating retrovirus infections therewith
12/06/1994	CA1333360C Tocopherol-based pharmaceutical systems
12/06/1994	CA1333359C Dental therapy by vesicle delivery
12/06/1994	CA1333346C Feed additive for ruminants
12/03/1994	CA2124633A1 Starch-based food enhancement
12/01/1994	DE4418115A1 Pharmaceutical preparations contg macrolide antibiotics
12/01/1994	DE4318375A1 Mixture for providing film coatings for tablets or the like
12/01/1994	DE4317646A1 Tablets containing thioctic acid and at least one basic component
12/01/1994	CA2124631A1 Preparation for dietetic use or as a food supplement, with targeted release in the colon
11/1994
11/30/1994	EP0626445A2 Detergent compositions
11/30/1994	EP0626385A1 Tetrahydropyran derivatives
11/30/1994	EP0626193A1 Positively charged polyvinylidene fluoride membrane
11/30/1994	EP0626173A1 Aerosol composition containing fusafungine
11/30/1994	EP0626172A1 Veterinary composition for treating and/or preventing infections and deseases
11/30/1994	EP0626171A1 Oxytetracycline or doxycycline injectable solution containing PVP and N-methylpyrrolidone and/or 2-pyrrolidone
11/30/1994	EP0626170A2 Stabilisation of pharmacologically active compounds in sustained release compositions
11/30/1994	EP0626169A2 A dosage form comprising an antigen and a salt form of an organic acid derivative of a sterol
11/30/1994	EP0626168A1 Novel rafting antacid composition
11/30/1994	EP0625993A1 Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
11/30/1994	EP0625906A1 Compositions for the treatment of pylori and dermatitis
11/30/1994	EP0625904A1 Bimodal molecular weight hyaluronate formulations and methods for using same
11/30/1994	EP0625901A1 Copolymer-based films, applications thereof in transdermal systems and processes for their preparation
11/30/1994	EP0625900A1 Compositions and processes for the sustained release of drugs.
11/30/1994	EP0625899A1 Liposomal itraconazole formulations.
11/30/1994	EP0625898A1 Liposomal piroxicam formulations.
11/30/1994	EP0543868B1 Dressing system
11/30/1994	EP0422164B1 Large multivalent immunogen
11/30/1994	CN2183763Y Telescopic sealed medical rod for external use
11/30/1994	CN1095617A Application of ginseng, and its vigour strengthening instant powder and prepn. method
11/30/1994	CN1095613A Clunese medicinal cream and prepn. method for treatment of skin scar increament and pigmentation
11/30/1994	CN1095612A Chinese medicinal wet burns cream
11/30/1994	CN1095611A Butter daisy injection and its preparation series
11/30/1994	CN1095609A Sexual cleaning lotion made of pure Chinese medicine
11/30/1994	CN1095605A Heart, brain and kidney health-care solution and prodn. method
11/30/1994	CN1095588A Zhuang medical thread and its prodn.
11/30/1994	CN1095586A Oral compositions
11/29/1994	US5369131 Oral, cutaneous and intravaginal pharmaceutical compositions in the form of foam
11/29/1994	US5369130 Solvent-free rubber with filler as adhesives
11/29/1994	US5369096 Glycolipid derivatives
11/29/1994	US5369095 Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers
11/29/1994	US5368868 Nonionic surfactants of ethylene propylene oxide copolymers
11/29/1994	US5368865 Suspendible composition and process for preparing the same
11/29/1994	US5368864 Formulation of oxypurinol and/or its alkali and alkaline earth salts
11/29/1994	US5368863 Long-term delivery device with early startup
11/29/1994	US5368862 Controlled delivery of drugs
11/29/1994	US5368861 Gastric preparation with sustained release
11/29/1994	US5368860 Preparation for transdermal drug administration
11/29/1994	US5368859 Biodegradable system for regenerating the periodontium
11/29/1994	US5368858 Methods and compositions for the treatment and repair of defects or lesions in cartilage
11/29/1994	US5368852 Prolonged-release liquid type of pharmaceutical preparation comprising drug-resin complex and benzoate preservative
11/29/1994	US5368848 Cosmetic gel stick compositions
11/29/1994	US5368847 Cosmetics, dermatology
11/29/1994	US5368842 High efficacy aerosol antiperspirant composition
11/29/1994	US5368588 Parenteral fluid medication reservoir pump
11/29/1994	CA2122949A1 Veterinary composition for treating and/or preventing infections and diseases
11/29/1994	CA2021282C Dispenser comprising ionophore
11/29/1994	CA1333316C Processes for microemulsion polymerization employing novel microemulsion systems
11/29/1994	CA1333258C Transmucosal formulations
11/29/1994	CA1333257C Use of zinc hydroxide or iron hydroxide as adjuvant in antigen solutions, and antigen solutions containing such adjuvants
11/28/1994	EP0663013A4 Method for delivering nucleic acids into cells.
11/28/1994	CA2124277A1 Methods for administering biological agents and microparticle compositions useful in these and other methods
11/26/1994	CA2124179A1 New fusafungine-based medicinal spray formulation, a process for its production and pharmaceuticals containing same
11/25/1994	CA2123534A1 Rafting antacid formulation
11/24/1994	WO1994026888A1 Inhibition of proliferation of vascular smooth muscle cell
11/24/1994	WO1994026778A1 Conjugation-stabilized polypeptide compositions
11/24/1994	WO1994026346A1 Method and device for the production of a transdermal therapeutic system
11/24/1994	WO1994026310A1 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
11/24/1994	WO1994026309A1 Solubilizing agent and external preparation containing the same
11/24/1994	WO1994026302A1 Stable liquid compositions of gamma interferon
11/24/1994	WO1994026291A1 Therapeutic inhibitor of vascular smooth muscle cells
11/24/1994	WO1994026270A1 Transdermal therapeutic systems for the administration of serotonin agonists
11/24/1994	WO1994026267A1 Compositions in the form of solid solutions
11/24/1994	WO1994026266A1 High dose formulations
11/24/1994	WO1994026257A1 Transdermal therapeutic system containing estradiol
11/24/1994	WO1994026256A1 Agglomerated psyllium hydrophilic mucilloid combinates
11/24/1994	WO1994026255A1 Solid fat nanoemulsions as vaccine delivery vehicles
11/24/1994	WO1994026254A1 Incorporation of taxol into liposomes and gels
11/24/1994	WO1994026253A1 Liposome having a multicomponent bilayer which contains a bioactive agent as an integral component of the bilayer
11/24/1994	WO1994026252A1 Solid fat nanoemulsions as drug delivery vehicles
11/24/1994	WO1994026251A1 Subcutaneous liposome delivery method
11/24/1994	WO1994026250A1 Method for treating neurological disorders
11/24/1994	WO1994026249A1 Compositions and methods for reparation and prevention of fibrotic lesions
11/24/1994	WO1994026238A1 Use of a vinyl lactam derived terpolymer as foaming agent in aerosol foam-forming compositions, and composition thereby obtained
11/24/1994	WO1994026234A1 Water-in-oil emulsion compositions
11/24/1994	WO1994026218A1 Foam laminate transdermal patch
11/24/1994	WO1994026208A1 Methods and formulations for use in treating oophorectomized women
11/24/1994	WO1994026207A1 Methods and formulations for use in treating benign gynecological disorders
11/24/1994	WO1994026113A2 Pour-on formulations containinng polymeric material, glycols and glycerides
11/24/1994	WO1994026110A1 Stable quinolone and naphthyridine premix formulations
11/24/1994	WO1994022441A3 Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases
11/24/1994	WO1994016709A3 Therapeutic uses and delivery systems of dehydroepiandrosterone
11/24/1994	DE4317078A1 Method of maintaining the optimum oxygen content of the eye required for the vision of the healthy human being, especially of contact lens wearers
11/24/1994	DE4316733A1 Dispenser for the controlled discharge of active substances
11/24/1994	DE4316727A1 Composition for the treatment of inflammatory disorders of the lower colonic region and of the skin with beclomethasone as active ingredient
11/24/1994	DE4316726A1 Composition for the treatment of cutaneous disorders with hydrocortisone acetate as active ingredient
11/24/1994	CA2455985A1 Therapeutic inhibitor of vascular smooth muscle cells

1 ... 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 ... 2991